Left Menu
Development News Edition

Zydus Cadila gets USFDA nod for multiple sclerosis treatment drug

The group now has 303 approvals and has so far filed over 390 abbreviated new drug applications since the commencement of the filing process in 2003-04. Cipla on Friday said it has also received final approval from the USFDA for Dimethyl Fumarate capsules.

PTI | New Delhi | Updated: 25-09-2020 11:17 IST | Created: 25-09-2020 11:07 IST
Zydus Cadila gets USFDA nod for multiple sclerosis treatment drug
File photo Image Credit: Twitter (@ZydusUniverse)

Drug firm Zydus Cadila on Friday said it has received final approval from the US health regulator to market Dimethyl Fumarate delayed release capsules, indicated for the treatment of patients with relapsing forms of multiple sclerosis. Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Dimethyl Fumarate delayed release capsules, (Tecfidera) in the strengths of 120 mg and 240 mg, Zydus Cadila, part of Cadila Healthcare group, said in a regulatory filing.

Zydus Cadila said in its approval, the USFDA noted that Zydus was one of the first abbreviated new drug application applicants to submit a substantially complete ANDA and is, therefore, eligible for 180 days of generic drug exclusivity along with other first ANDA applicants. "The USFDA granted approval following entry of judgment in favour of Zydus Cadila and other ANDA applicants by the United States District Court for the District of Delaware, holding that the only unexpired patent covering Tecfidera is invalid," the company added.

Zydus Cadila said the newly approved medication will be manufactured at the group's formulation manufacturing facility at the SEZ, Matoda. The group now has 303 approvals and has so far filed over 390 abbreviated new drug applications since the commencement of the filing process in 2003-04.

Cipla on Friday said it has also received final approval from the USFDA for Dimethyl Fumarate capsules. Quoting IQVIA (IMS Health) data, Cipla said Tecfidera had US sales of approximately USD 3.8 billion for the 12-month period ending July 2020.

Shares of Cadila Healthcare were trading 0.39 per cent lower at Rs 377.50 apiece on BSE.


TRENDING

OPINION / BLOG / INTERVIEW

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Guinea’s elections hearken back to the autocracy and violence of its past

... ...

Videos

Latest News

Protesters march through Belarus as opposition threatens national strike

Tens of thousands of people marched through Minsk and other cities on Sunday, keeping pressure on Belarusian President Alexander Lukashenko a day before the opposition threatens to launch a national strike if he refuses to resign. Crowds st...

We were not expressive enough: Virat Kohli

Royal Challengers Bangalore captain Virat Kohli on Sunday said that his team wasnt expressive enough during the IPL match against Chennai Super Kings but accepted that in a marathon league, there would be a defeat here and there. CSK beat R...

IPL 13: Mumbai Indians win toss, opt to bat first against Rajasthan Royals

Mumbai Indians have won the toss and opted to bat first against Rajasthan Royals here at Sheikh Zayed Stadium on Sunday. MI are at the top of the table with 14 points and have won their last fixture comfortably against Chennai Super Kings b...

Italy orders bars, restaurants to close early as COVID infections surge

Italy on Sunday ordered bars and restaurants to close by 6 p.m. and shut public gyms, cinemas and swimming pools to try to halt a rapid resurgence in the coronavirus that has pushed daily infection rates to new records. Prime Minister Giuse...

Give Feedback